HGCRD

07-01-2022 | LEVI | Guidance

Short
NYSE:LEVI   Levi Strauss & Co
Journal Entry

Bias: Negative.

Sentiment: Pessimistic.

Emoji (emotion): Pumped 🏋️.

Null Hypothesis: Sell.

Alternative Hypothesis: Buy, Buy then Sell.

Signals: ...

Position: Swing trade.

Notes: I'm anticipating the market to sell the earnings surprise 07-07-2022 AMC: https://www.estimize.com/levi/fq2-2022?metric_name=eps&chart=historical

Barron's Company Overview: https://www.barrons.com/market-data/stocks/levi?mod=searchresults_companyquotes&mod=searchbar

Other: ...

Tutorial: (Q/A) What exactly is the box labeled tolerance? The box labeled tolerance is a defined range of value & time that qualifies the right to exit the trade after a profit is made; as long as the security is inside the box and above the trade's entry one could say the profit is within tolerance, likewise if the security is outside the box either because of value or time one could say the profit is not within tolerance. It's a way to add parameters to the future outcome of the journal entry (as a means to grade the journal entry) while simultaneously providing leniency in the ability to achieve success with said journal entry.

About the Security: "Levi Strauss & Co. engages in the design, marketing, and sale of apparel products. The company offers jeans, casual and dress pants, tops, shorts, skirts, jackets, footwear, and related accessories. It operates through the following geographical segments: Americas, Europe, and Asia. The company was founded by Levi Strauss in 1853 and is headquartered in San Francisco, CA."

About the Author: I'm happy to hear from my readers/audience and I encourage constructive feedback; although I'm busy I will give my best effort to reply. I do strive to build an esteemed reputation with a prolific following as well as earn the titles of a Tradingview Wizard & Top Author; along those lines I'm a financial scientist and my contributions offered to the community are apart of my scientific journal or goodwill to mankind.

Disclaimer: My journal entry is not a complete prospectus, please consider it accordingly.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.